Director

Senior Vice President

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Institution	Shares	Value	Change
Vanguard	35,828,599	$4.8B	INCREASED
BlackRock	25,599,001	$3.4B	DECREASED
State Street	12,854,230	$1.7B	INCREASED
Massachusetts Financial Services Co /MA	10,010,867	$1.4B	DECREASED
T. Rowe Price	8,771,671	$1.2B	DECREASED

Insider	Type	Shares	Value	Date
Glenn S Boehnlein (Director)	AWARD	817	$120K	2026-09-08
Mikael Dolsten (Director)	SELL	634	$96K	2026-09-04
Jonah Prevost Kirkwood (Senior Vice President)	TAX-W	30	$4K	2026-06-26

Member	Type	Amount	Date
Julie Johnson (Democrat)	SALE	$1,001 - $15,000	2025-09-23
Julie Johnson (Democrat)	PURCHASE	$1,001 - $15,000	2025-09-23
Julie Johnson (Democrat)	PURCHASE	$1,001 - $15,000	2025-09-23

Agilent Technologies Inc. (A) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades